CoChat

A proteomic platform to identify off-target proteins associated with therapeutic modalities that induce protein degradation or gene silencing

Open access
Liu, Xin, Zhang, Ye, Ward, Lucas D., Yan, Qinghong, Bohnuud, Tanggis, Hernandez, Rocio, Lao, Socheata, Yuan, Jing, Fan, Fan · 2021 · Scientific Reports

Published version of a preprint

The DOI matches its Crossref record; 54 of the 57 references it cites were found in a registry or an index.

Abstract

Novel modalities such as PROTAC and RNAi have the ability to inadvertently alter the abundance of endogenous proteins. Currently available in vitro secondary pharmacology assays, which evaluate off-target binding or activity of small molecules, do not fully assess the off-target effects of PROTAC and are not applicable to RNAi. To address this gap, we developed a proteomics-based platform to comprehensively evaluate the abundance of off-target proteins. First, we selected off-target proteins using genetics and pharmacology evidence. This process yielded 2813 proteins, which we refer to as the "selected off-target proteome" (SOTP). An iterative algorithm was then used to identify four human cell lines out of 932. The 4 cell lines collectively expressed ~ 80% of the SOTP based on transcriptome data. Second, we used mass spectrometry to quantify the intracellular and extracellular proteins from the selected cell lines. Among over 10,000 quantifiable proteins identified, 1828 were part of the predefined SOTP. The SOTP was designed to be easily modified or expanded, owing to the rational selection process developed and the label free LC-MS/MS approach chosen. This versatility inherent to our platform is essential to design fit-for-purpose studies that can address the dynamic questions faced in investigative toxicology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-021-95354-3

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic workflow for the quantification of cellular proteome (A) and secretome (B).
Figure 1 Schematic workflow for the quantification of cellular proteome (A) and secretome (B).CC BY · PubMed Central
Figure 2 Systematic selection of SOTP and cell lines. (A) Venn diagram of SOTP composition. (B) Subcellular localization of SOTP. (C) Protein class of SOTP. (D) the similarity of primary protein structures between species.
Figure 2 Systematic selection of SOTP and cell lines. (A) Venn diagram of SOTP composition. (B) Subcellular localization of SOTP. (C) Protein class of SOTP. (D) the similarity of primary protein structures between species.CC BY · PubMed Central
Figure 3 Deep proteomic analysis of selected cell lines. (A) Venn diagram of proteins quantified in cellular proteome and secretome compared to SOTP (gene centric). (B) Proportion of proteins quantified in all and contributions of different cell lines.
Figure 3 Deep proteomic analysis of selected cell lines. (A) Venn diagram of proteins quantified in cellular proteome and secretome compared to SOTP (gene centric). (B) Proportion of proteins quantified in all and contributions of different cell lines.CC BY · PubMed Central
Figure 4 Relative distribution and absolute numbers of proteins in selected functional categories (A) and different organ classes (B). The coloring of the bars indicates fractions of proteins that are expressed in all or detected in certain number of cell lines.
Figure 4 Relative distribution and absolute numbers of proteins in selected functional categories (A) and different organ classes (B). The coloring of the bars indicates fractions of proteins that are expressed in all or detected in certain number of cell lines.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 25

Metadata

Authors
Liu, X., Zhang, Y., Ward, L. D., Yan, Q., Bohnuud, T., Hernandez, R., Lao, S., Yuan, J., & Fan, F.
Affiliations
Amgen (United States) (US)
Corresponding author
Fan, Fan
Venue
Scientific Reports
Published
2021-08-04
Volume
11
Issue
1
Pages
15856-15856
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3102038798
Cited by
21
References
57
Citations by year
2026: 5 · 2025: 3 · 2024: 8 · 2023: 3 · 2022: 2
FWCI
1.19
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Amgen
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
Keywords
PROTACs, RNA interference, protein degradation, gene silencing, cell line selection, off-target effects
MeSH terms
Humans, Neoplasms, Tumor Cells, Cultured, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Proteome, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A proteomic platform to identify off-target proteins associated with therapeutic modalities that induce protein degradation or gene silencing. https://app.cochat.ai/papers/10.1038/s41598-021-95354-3
The paper
Liu, X., Zhang, Y., Ward, L. D., Yan, Q., Bohnuud, T., Hernandez, R., Lao, S., Yuan, J., & Fan, F. (2021). A proteomic platform to identify off-target proteins associated with therapeutic modalities that induce protein degradation or gene silencing. Scientific Reports. https://doi.org/10.1038/s41598-021-95354-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.